Recommended

Resilient supply: safeguarding Europe’s generics
Sanofi’s ‘factory of the future’ vision
AI Act: data governance and compliance implications
mRNA vaccine research cut by RFK Jr
EU Biotech Act public consultation opens
FDA PreCheck programme encourages new manufacturing sites
President Trump targets US pharma supply chain resilience
CDMO Ofichem acquires Uppsala site from Meribel
webinar

Variable pathlength spectroscopy for dilution-free concentration measurement in GMP environments

24 June 2021

Shares

56

Watch this on-demand webinar, where we reviewed VPT and how it can be used in various applications, from protein therapeutics to gene therapy.

Traditional ultraviolet–visible (UV/Vis) spectroscopy uses fixed pathlengths to measure different analytes, such as nucleic acids, proteins and cells from biological samples. These samples are often limited in volume or highly concentrated, which presents various challenges.

The CTech™ SoloVPE® System uses a patented variable pathlength technology (VPT) to accurately measure the targeted concentration of various analytes. The system can measure concentrations without being dependent on sample volume or sample concentration, removing any dilution requirements.

In this on-demand webinar, we reviewed VPT and how it can be used in various applications, from protein therapeutics to gene therapy. We also shared real-world case studies demonstrating how companies have integrated the SoloVPE system into their manufacturing workflow for release and in-process testing.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Key learning points

  • The science of slope spectroscopy and why variable pathlength is better than fixed pathlength
  • Overview of the SoloVPE System and the benefits:
    • No sample dilutions
    • Guaranteed linear results
    • No baseline correction
    • Testing of low and very high concentration samples from 0.01mg/mL up to 300mg/mL (MAbs)
    • Implementing in the analytics/QC lab or in the production suite for at-line testing (IPT)
  • Review SoloVPE implementation in multiple applications – Quantitate proteins (A280, DNA/RNA, PS280, gold particle testing, plasmid purity)

Meet our speaker

Dean Barton, Analytical Sales Manager, Repligen 

Dean Barton is an Analytics Sales Manager at Repligen for Northern Europe. He spent the last 15 years in both technical and commercial roles supporting the biopharma, food safety, animal health and academic industry to implement rapid analytical solutions.

For the past six years he has focussed on biopharma manufacturing, development and QC groups to help them achieve their goals of faster analytics; improved production processes and efficiencies; and advancing scientific discovery with molecular biology and spectroscopy solutions.

Share via